Amplia Therapeutics Ltd.ASX: ATX

Phase 2B Trial of MIS416 on Schedule to Complete April 2017

Feb 28, 2017 at 2:49 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment